Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Gynecology · Vaginal Leukoplakia

The Diagnostic Process and Your Pathology Report

At a Glance

A white patch in the vagina cannot be classified reliably by appearance alone. Colposcopy helps target a biopsy, and the laboratory report determines whether the change is harmless, a low- or high-grade precancerous lesion, or invasive cancer.

While a visual exam can identify a white patch, it cannot tell your care team what the cells are doing beneath the surface. Because the appearance of leukoplakia (a white patch) can be caused by anything from harmless irritation to high-grade precancer, the diagnostic process must move from “looking” to “testing” [1][2].

The Role of Vaginal Colposcopy

Evaluation usually begins with a complete vulvovaginal and speculum examination. As an adjunct to this, a doctor may use a specialized magnifying instrument called a colposcope to look closely at the walls of the vagina [3]. They may apply a vinegar-like solution (acetic acid) or an iodine solution (Lugol’s) to the area to make abnormal cells easier to see [4].

It is important to know that while colposcopy is a vital tool for targeting a biopsy, it is not perfectly accurate on its own. In various studies, doctors’ visual impressions sometimes misidentified high-grade disease or could not distinguish it from benign changes [4][5]. This is why colposcopy is used to guide a biopsy, rather than replace it.

What to Expect During a Biopsy

A colposcopy-directed biopsy—taking a small sample of the tissue for lab analysis—is the most reliable way to establish a diagnosis [2].

  • The Procedure: Your doctor will use the colposcope to find the most suspicious part of the white patch and take a tiny piece of it (often the size of a grain of rice).
  • Sensation: You may feel a pinch, pressure, or a brief sharp cramping sensation. Some doctors use a local anesthetic to numb the area, though not always.
  • Aftercare: You can expect some light spotting or a dark discharge (if a liquid bandage called Monsel’s solution was used) for a few days. Your doctor will likely advise you to avoid tampons, intercourse, and submerging in water until the area heals.

In some cases, a small punch biopsy might not provide enough information. If the lab report states that “invasion cannot be excluded,” it means the pathologist cannot tell for sure if the abnormal cells have started to spread into deeper layers of tissue [2]. This does not automatically mean you have cancer; it simply means a larger procedure called an excisional biopsy (removing the entire patch) may be required to get a definitive answer [6].

Understanding Your Pathology Report

The pathology report is the document that guides your treatment. It translates the white patch into a specific medical diagnosis. To be complete, your report may contain several key data points:

1. The Grade of the Lesion

If the diagnosis is VaIN (changes associated with HPV), it should be graded using two different systems:

  • The Binary System: This classifies cells as either vLSIL (Low-grade Squamous Intraepithelial Lesion) or vHSIL (High-grade Squamous Intraepithelial Lesion) [7].
  • The Numeric System: This provides more detail, ranking the changes from VaIN 1 (mild viral effect) to VaIN 2 or VaIN 3 (more severe, true precancer) [2].

2. Specialized Staining (Immunohistochemistry)

Pathologists sometimes selectively use special “stains” to help confirm a diagnosis when cells look equivocal under a standard microscope. These are not required on every report.

  • p16: This is a protein marker used as a surrogate for high-risk HPV activity. A “strong and diffuse” p16 result often supports a diagnosis of high-grade precancer (vHSIL/VaIN 2-3) when it matches the visual morphology [7].
  • Ki-67: This marker shows how fast cells are dividing. While helpful, it is used alongside other findings and is not a stand-alone test [8].

3. Exclusion of Invasive Cancer

One of the most critical parts of the report is assessing whether the abnormal cells have invaded the deeper tissue. If the report mentions stromal invasion, it indicates that the condition has progressed beyond precancer to invasive cancer [2].

Pathology Report Completeness Checklist

You can use this checklist to ensure you and your doctor have all the information needed to move forward. (Note: Not all items are required for every biopsy, but they are useful concepts to ask about.)

Data Point Why It Matters
Site Identification Confirms exactly where (vagina vs. vulva) the sample was taken.
Specific Diagnosis Distinguishes between benign changes, inflammatory dermatoses, or VaIN [9].
Specific Grade Distinguishes between low-grade (vLSIL/VaIN 1) and high-grade (vHSIL/VaIN 2-3) [7].
Invasion Status Clearly states if invasive cancer was seen or if it “cannot be excluded” [6].
Ancillary Stains Notes if p16 or other markers were selectively used to confirm the diagnosis [2].

If any of these points are missing or unclear, it is a good starting point for a conversation with your healthcare team. You may even request that your slides be reviewed by a specialized gynecologic pathologist for a second opinion if the results are complex or do not match what the doctor saw during the exam [10].

Common questions in this guide

Can a colposcopy alone diagnose a vaginal white patch?
No. Colposcopy magnifies the tissue and helps the clinician choose the most suspicious area, but visual findings cannot reliably distinguish irritation or benign changes from precancer. A tissue biopsy examined in the laboratory is the most reliable way to establish the diagnosis.
What do VaIN 1, VaIN 2, and VaIN 3 mean?
These are numeric grades for HPV-related changes in vaginal tissue. VaIN 1 describes milder low-grade changes, while VaIN 2 and VaIN 3 describe more severe high-grade precancerous changes. Reports may also use vLSIL for low-grade and vHSIL for high-grade lesions.
What do p16 and Ki-67 mean on a vaginal pathology report?
p16 is a marker that can support high-risk HPV-related high-grade precancer when its pattern matches what the cells look like under a microscope. Ki-67 provides information about how quickly cells are dividing. Neither stain is interpreted by itself; the pathologist considers the full tissue appearance and other findings.
What does “invasion cannot be excluded” mean on my biopsy report?
It means the small tissue sample does not allow the pathologist to determine with certainty whether abnormal cells have grown into deeper tissue. It does not automatically mean that cancer is present. A larger excisional biopsy that removes the whole patch may be recommended to clarify the diagnosis.
What does stromal invasion mean in vaginal pathology?
Stromal invasion means abnormal cells have entered the deeper supporting tissue beneath the surface. In this setting, it indicates invasive cancer rather than a precancerous lesion. Your gynecologic team can explain the result and the next steps for your care.
What information should a vaginal leukoplakia pathology report include?
It should identify the sampled site and give a specific diagnosis, grade when relevant, and clear information about whether invasion is present or cannot be excluded. It may also list p16 or other stains used to clarify the diagnosis. If the findings are complex or do not match the examination, a review by a gynecologic pathologist may be helpful.

Get notified when new evidence is published on leukoplakia of vagina.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Erosive Lichen Sclerosus-A Clinicopathologic Subtype.

    Day T, Otton G, Dennerstein G, et al.

    Journal of lower genital tract disease 2021; (25(3)):255-260 doi:10.1097/LGT.0000000000000607.

    PMID: 33859124
  2. 2

    The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.

    Kesic V, Carcopino X, Preti M, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(4)):446-461 doi:10.1136/ijgc-2022-004213.

    PMID: 36958755
  3. 3

    Abnormal Pap Smear and Diagnosis of High-Grade Vaginal Intraepithelial Neoplasia: A Retrospective Cohort Study.

    Sopracordevole F, Mancioli F, Clemente N, et al.

    Medicine 2015; (94(42)):e1827 doi:10.1097/MD.0000000000001827.

    PMID: 26496321
  4. 4

    Application of 2011 International Federation for Cervical Pathology and Colposcopy Terminology on the Detection of Vaginal Intraepithelial Neoplasia.

    Zhou Q, Zhang F, Sui L, et al.

    Cancer management and research 2020; (12()):5987-5995 doi:10.2147/CMAR.S257875.

    PMID: 32765098
  5. 5

    Screening History in Vaginal Precancer and Cancer: A Retrospective Study of 2131 Cases in China.

    Zhang L, Wang Q, Zhang H, et al.

    Cancer management and research 2021; (13()):8855-8863 doi:10.2147/CMAR.S335701.

    PMID: 34858059
  6. 6

    Vaginal Intraepithelial Neoplasia: Histopathological Upgrading of Lesions and Evidence of Occult Vaginal Cancer.

    Sopracordevole F, De Piero G, Clemente N, et al.

    Journal of lower genital tract disease 2016; (20(1)):70-4 doi:10.1097/LGT.0000000000000150.

    PMID: 26461231
  7. 7

    [Nomenclature of squamous cell precursor lesions of the lower female genital tract : Current aspects].

    Horn LC, Brambs CE, Handzel R, et al.

    Der Pathologe 2016; (37(6)):526-533 doi:10.1007/s00292-016-0239-8.

    PMID: 27738814
  8. 8

    Assessment of CK17 as a Marker for the Diagnosis of Differentiated Vulvar Intraepithelial Neoplasia.

    Podoll MB, Singh N, Gilks CB, et al.

    International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2017; (36(3)):273-280 doi:10.1097/PGP.0000000000000317.

    PMID: 27513074
  9. 9

    Clinicopathologic Diagnostic Criteria for Vulvar Lichen Planus.

    Day T, Wilkinson E, Rowan D, et al.

    Journal of lower genital tract disease 2020; (24(3)):317-329 doi:10.1097/LGT.0000000000000532.

    PMID: 32205763
  10. 10

    [Vaginal Follicular dendritic cell sarcoma in patient with previous urinary tract carcinoma. Case Report].

    Zaya AM, González AC, Sandrone SS, Sambuelli RH

    Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) 2016; (73(2)):126-31.

    PMID: 27420147

This page is for informational purposes only and does not constitute medical advice. Your gynecologist and pathologist can interpret your vaginal biopsy and explain the next steps for your specific situation.